---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-036862"
form_type: "8-K"
ticker: "ASTH"
cik: "0001083446"
company_name: "Astrana Health, Inc."
filed_at: "2026-03-30T23:59:59+00:00"
generated_at: "2026-05-15T08:20:07.292912+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Astrana Health files interim financials of acquired Prospect entities; pro forma included

## Summary
- Acquired Business (PHPH & RI Market) nine-month net loss $38.7M vs $43.7M year-ago; total net revenue $961.8M (+9.6% YoY).
- Operating income $48.5M vs $88.4M YoY; interest expense $121.8M drove pre-tax loss $73.4M.
- Members' deficit $1.31B as of June 30, 2025, with long-term debt $777.8M and current debt $489.0M.
- Pro forma condensed combined statement of operations for Astrana for fiscal year 2025 filed as Exhibit 99.2.

## SEC filing metadata
- accession: 0001104659-26-036862
- form_type: 8-K
- ticker: ASTH
- cik: 0001083446
- company_name: Astrana Health, Inc.
- filed_at: 2026-03-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1083446/000110465926036862/0001104659-26-036862-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1083446/000110465926036862/tm269272d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-036862
- JSON: https://secwatch.observer/filing/0001104659-26-036862.json
- Plain text: https://secwatch.observer/filing/0001104659-26-036862.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.